El Helali, A
View More
| Keywords in Publications | |
|---|---|
| keywords | No. of Authors |
| molecular tumour board | 10 |
| next-generation sequencing | 10 |
| precision oncology | 10 |
| sequence-directed therapy | 10 |
| bintrafusp alfa | 8 |
| correlative biomarkers | 8 |
| efficacy | 8 |
| recurrent or metastatic nasopharyngeal cancer | 8 |
| safety | 8 |
| breast cancer | 4 |
| country income | 3 |
| deep learning | 3 |
| fibers | 3 |
| low-dose volume | 3 |
| lymphopenia | 3 |
| radiotherapy (rt) | 3 |
| sodium | 3 |
| trend | 3 |
| whole grains | 3 |
| advanced gastric adenocarcinoma | 2 |
| immune checkpoint inhibition (ici) | 2 |
| microsatellite instability (msi) | 2 |
| pd-l1 | 2 |
| tumor mutational burden (tmb) | 2 |
| adenosine triphosphate (atp) | 1 |
| colorectal cancer | 1 |
| drug combination | 1 |
| hormone therapy | 1 |
| mapk | 1 |
| metastasis-associated antigen 1 (mta1) | 1 |
| mitochondrial glucose metabolism | 1 |
| mtor inhibitors | 1 |
| ovarian cancer | 1 |
| qol | 1 |
| quality of life | 1 |
| resistance | 1 |
| src | 1 |
| survival | 1 |